|
Post by kc on Jan 2, 2018 14:28:25 GMT -5
Here we go again with H.C. Wainwright? Are we going to see the same deal happen again? WASH, RINSE AND REPEAT?
MannKind (NASDAQ:MNKD): H.C. Wainwright Reconfirms Buy Rating Today, Has a Target of $7.0/Share MannKind (NASDAQ:MNKD) Rating Reaffirmed
They currently have a $7.0 PT on MannKind (NASDAQ:MNKD). The target price by H.C. Wainwright would suggest a potential upside of 200.43 % from the company’s previous close. This has been revealed to investors in a research note on Tuesday morning.
bzweekly.com/mannkind-nasdaqmnkd-h-c-wainwright-reconfirms-buy-rating-today-has-a-target-of-7-0-share/
I hope its not a phony deal or repeat of last October. I'd take another round of smoke and mirrors if they can pull it off. I've got some options expiring this month, and worthless unless we get a bounce. I'm not overly hopeful they can pull it off a second time. If only I'd been a bit more suspect of the last smoke screen and sold my Jan 2018 calls. Everyone knows me, however... always being too optimistic Give me the Smoke and Mirrors with a Stock offering at $15.00 per share or a buy in at $15.00 per share for 15% or 20% of the company. Then you will see the RAT'S being FRIED.
|
|
|
Post by kc on Jan 2, 2018 12:49:12 GMT -5
Here we go again with H.C. Wainwright? Are we going to see the same deal happen again? WASH, RINSE AND REPEAT?
MannKind (NASDAQ:MNKD): H.C. Wainwright Reconfirms Buy Rating Today, Has a Target of $7.0/Share MannKind (NASDAQ:MNKD) Rating Reaffirmed
They currently have a $7.0 PT on MannKind (NASDAQ:MNKD). The target price by H.C. Wainwright would suggest a potential upside of 200.43 % from the company’s previous close. This has been revealed to investors in a research note on Tuesday morning.
bzweekly.com/mannkind-nasdaqmnkd-h-c-wainwright-reconfirms-buy-rating-today-has-a-target-of-7-0-share/
I hope its not a phony deal or repeat of last October.
|
|
|
Post by kc on Jan 2, 2018 12:27:27 GMT -5
Pre-diabetes cure according to Al Mann was Afrezza for pre-type 2.
|
|
|
Post by kc on Jan 2, 2018 11:53:19 GMT -5
nice to make 24.25% on loaned shares.
|
|
|
Post by kc on Jan 2, 2018 11:46:45 GMT -5
I know I've seen some recs on this page before, but I can't seem to find those threads. I'm interested in learning more about trading options. Since I strongly believe in the potential of afrezza, what better time to get my feet wet with some call options in MNKD! Although I've read a lot over the past couple years, I have no experience in options. I would love to benefit from the wisdom of some the more experienced fellow longs on this board (basically directing this at you sports . What are some examples of the more recent call options you all bought? Planning on buying? I own a lot of the stock, and I would like to reduce my risk a little by selling some shares, and replacing them with call options. Any advice appreciated!!!...except advice about how risky it is, and how I shouldn't do it because I'm inexperienced. I understand the risk, but you have to learn somehow. Thanks! ?? Why is selling some shares and replacing them with call options less risky? I consider options to be risky, but minimal if you know what you're doing. Newbies see people making $$$, but jump in without knowing or having the knowledge to handle it. I also use to day trade a lot ... unless you have the time to be watching the board constantly, you are in the wrong track. Study options first ... before you put any cash into it. If you think you can handle it ... then, jump in. As I've always said ... the fastest way to learn something is through PAIN! I have always been a buy and hold guy! Have never taken the time to figure out options. I know that Sports would teach me but I have to take the time to learn. I guess that I'm an old dog.....
|
|
|
Post by kc on Jan 1, 2018 12:53:12 GMT -5
Yes, VERY. Don’t think this is just because. They have something lined up otherwise would have been IMO a bad usage of funds atm. I think we get some news this week. First week of 2017 they made three announcements. We will see what they do this week or next.
|
|
|
Post by kc on Dec 31, 2017 20:14:07 GMT -5
Hostile takeover!!?? Sorry at 300$/sh I sell... I know I'm horrible😂 Heck - I'll give them a bargain - they can have mine for $200/sh. At $200 for sure I would owe a lot of tax. 👍
|
|
|
Post by kc on Dec 31, 2017 8:50:09 GMT -5
On a Sunday AM. Wow!
|
|
|
Post by kc on Dec 29, 2017 22:56:51 GMT -5
I think Nate is smoking something. But I hope he’s right. 50 billion would mean Afrezza is doing 5 billion/year in sales. Making that kind of projection right now is ridiculous, and reduces his credibility. 50 Billion. Oh my! I’m rich 💰💰💰💰💰
|
|
|
Post by kc on Dec 27, 2017 17:34:25 GMT -5
perhaps CELG needs to buy into a new company (MannKind), only Buy into as we are not for sale right now. But they could have a 15% or 20% stake at $20.00 per share and provide us the marketing muscle like Sanofi does for Regeneron. $20.00 buy in would be a great way to utilize the newly minted treasury shares. That would be a red hot way to burn the shorts. Where do you get these numbers from? I'm all for someone buying in, but at this point it's more likely $2.50 - $3/share. They would not sell a % for that amount. That is why they tested the water with the $6.00 offering. They now have the shares to make a deal for a % of the company if the deal was good for the company. I believe that would have been Al Mann’s wishes.
|
|
|
Post by kc on Dec 27, 2017 16:17:31 GMT -5
perhaps CELG needs to buy into a new company (MannKind), only Buy into as we are not for sale right now. But they could have a 15% or 20% stake at $20.00 per share and provide us the marketing muscle like Sanofi does for Regeneron. $20.00 buy in would be a great way to utilize the newly minted treasury shares. That would be a red hot way to burn the shorts.
|
|
|
Post by kc on Dec 27, 2017 14:02:02 GMT -5
Tell the “too old” thing to CEO’s like Warren Buffet, Sumner Redstone, Roger Penske.... and to Santa Clause, Jesus, and God for that matter 😎 I think that Sumner Redstone is now in La La land.
|
|
|
Post by kc on Dec 27, 2017 13:13:03 GMT -5
I subscribe to Barrons.
MannKind CEO, Exec Bought Stock in December
|
|
|
Post by kc on Dec 27, 2017 11:59:41 GMT -5
I do not want to get too excited. But the doctor Michael Friedman who is on mannkinds‘s board is 73 years of age. I would hope that perhaps there is Another Michael Friedman who might be a younger doctor becoming the CMO for MannKind. Not to be to Ethnocentric, in the Jewish community with the name Friedman there are lots of doctors. Sort of like Smith might be in other communities. Here's some background on Dr. Friedman and it looks like you're right kc..... www.celgene.com/about/leadership/board-of-directors/His Bio and leadership is fantastic. He is a well sought after board member and I love my Intuitive Surgical stock. but most companies would not hire a 73 year old CMO.
|
|
|
Post by kc on Dec 26, 2017 22:32:37 GMT -5
I do not want to get too excited. But the doctor Michael Friedman who is on mannkinds‘s board is 73 years of age. I would hope that perhaps there is Another Michael Friedman who might be a younger doctor becoming the CMO for MannKind.
Not to be to Ethnocentric, in the Jewish community with the name Friedman there are lots of doctors. Sort of like Smith might be in other communities.
|
|